IQVIA Holdings's average Accounts Receivable for the
three
months ended in Jun. 2024 was $1,397 Mil. IQVIA Holdings's Revenue for the
three
months ended in Jun. 2024 was $3,814 Mil.
Hence, IQVIA Holdings's Days Sales Outstanding for the
three
months ended in Jun. 2024 was 33.42.
The historical rank and industry rank for IQVIA Holdings's Days Sales Outstanding or its related term are showing as below:
IQV'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 28.54 Med: 37.09 Max: 43.96
Current: 33.5
During the past 13 years, IQVIA Holdings's highest Days Sales Outstanding was 43.96. The lowest was 28.54. And the median was 37.09.
IQV's Days Sales Outstanding is ranked better than 84.58% of 214
companies
in the Medical Diagnostics & Research industry
Industry Median: 66.995
vs IQV: 33.50
IQVIA Holdings's Days Sales Outstanding
increased
from Jun. 2023 (32.92) to Jun. 2024 (33.42).
IQVIA Holdings Days Sales Outstanding Historical Data
The historical data trend for IQVIA Holdings's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of IQVIA Holdings's Days Sales Outstanding
For the Diagnostics & Research subindustry, IQVIA Holdings's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IQVIA Holdings's Days Sales Outstanding Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, IQVIA Holdings's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where IQVIA Holdings's Days Sales Outstanding falls into.
IQVIA Holdings Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IQVIA Holdings (NYSE:IQV) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
IQVIA Holdings Days Sales Outstanding Related Terms
Thank you for viewing the detailed overview of IQVIA Holdings's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
IQV has been successfully added to your 